Why these 4 ASX shares are ending the week deep in the red

The Webjet Limited (ASX:WEB) share price is one of four ending the week in the red. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a disappointing end to the week for the benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In afternoon trade the index is down 1.3% to 5,711 points.

Four shares which have fallen significantly more than average today are listed below. Here's why they are ending the week deep in the red:

The Ellex Medical Lasers Limited (ASX: ELX) share price is down 5% to $1.02 following the release of a trading update. According to the release, the medical device company expects to post a loss before tax of $2 million in FY 2017. This has been blamed on a stronger Australian dollar and investment in its iTrack device.

The Mayne Pharma Group Ltd (ASX: MYX) share price has fallen almost 4% to 95.2 cents. Whilst I think the pharmaceutical company's shares are arguably dirt cheap right now, until the Trump Administration has finalised its plans on generic drug prices, I would suggest investors stay clear of the company's shares.

The OceanaGold Corporation (ASX: OGC) share price is down 6.5% to $3.34 following the release of its second-quarter update. The market appears to have been left underwhelmed by management's full-year production guidance of between 550,000 and 600,000 ounces of gold. Whilst its shares are cheaper now, I still feel there is better value for money elsewhere in the sector.

The Webjet Limited (ASX: WEB) share price has fallen 7% to $11.80 after the online travel agent advised that its auditor BDO Audit disagreed with a technical accounting matter relating to its financial statements for the year ending 30 June 2017. If BDO's methodology were applied to its full-year results, it would reduce EBITDA by $11.5 million. Today's decline could potentially be a buying opportunity in my opinion.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »